Telix Drug Patent Portfolio
Telix owns 1 orange book drug protected by 1 US patent Given below is the list of Telix's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11027031 | Kit for radiolabelling | 28 Jul, 2035 | Active |
Latest Legal Activities on Telix's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Telix.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 16 Aug, 2023 | US11027031 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 08 Nov, 2022 | US11027031 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 19 Sep, 2022 | US11027031 |
|
Recordation of Patent Grant Mailed
Critical
| 08 Jun, 2021 | US11027031 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 08 Jun, 2021 | US11027031 |
|
Issue Notification Mailed
Critical
| 19 May, 2021 | US11027031 |
| Dispatch to FDC | 10 May, 2021 | US11027031 |
|
Application Is Considered Ready for Issue
Critical
| 07 May, 2021 | US11027031 |
|
Issue Fee Payment Verified
Critical
| 06 May, 2021 | US11027031 |
|
Issue Fee Payment Received
Critical
| 06 May, 2021 | US11027031 |
| Filing Receipt - Corrected | 08 Apr, 2021 | US11027031 |
| Miscellaneous Incoming Letter | 07 Apr, 2021 | US11027031 |
|
Mail Notice of Allowance
Critical
| 31 Mar, 2021 | US11027031 |
|
Notice of Allowance Data Verification Completed
Critical
| 30 Mar, 2021 | US11027031 |
|
Information Disclosure Statement considered
Critical
| 27 Mar, 2021 | US11027031 |
Telix's Family Patents
Telix drugs have patent protection in a total of 18 countries. It's US patent count contributes only to 21.3% of its total global patent coverage. Click
below to unlock the full patent family tree.
Telix Drug List
Given below is the complete list of Telix's drugs and the patents protecting them.
1. Illuccix
Illuccix is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11027031 | Kit for radiolabelling |
28 Jul, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Illuccix's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List